Amcare Labs, an Affiliate of Johns Hopkins Medicine International, and Biophysical Corporation Partner to Provide Biophysical250 Health Assessment to Tokyo Midtown Medical Center

Tokyo Midtown Medical Center has exclusive rights to offer Biophysical250® in Japan.

We are delighted to work with innovators in the medical assessment field such as Biophysical Corporation and are pleased that the Biophysical250 will be used by the Tokyo Midtown Medical Center and available in Japan

Austin, Texas (PRWEB) September 17, 2007 -- Biophysical Corporation® announced today that it has partnered with Amcare Labs International, Inc., an affiliate of Johns Hopkins Medicine International, to offer the Biophysical250® health assessment at the Tokyo Midtown Medical Center in Tokyo, Japan. Tokyo Midtown Medical Center has exclusive rights in Japan to offer the Biophysical250 to their patients.

Biophysical Corporation's Biophysical250 is an innovative health assessment that provides the single most comprehensive evaluation of an individual's health available to date. Compared with standard physicals that typically only look at 20-40 biomarkers (proteins in the blood like glucose and cholesterol), Biophysical250 measures those same biomarkers, plus those used routinely by 12 different medical specialties, including cardiology, oncology and rheumatology, for a total of more than 250 different biomarkers. With a blood sample of approximately two tablespoons, the Biophysical250 provides an assessment that can help indicate the presence of certain diseases and medical conditions at their earliest stages, often before symptoms appear.

"We are delighted to work with innovators in the medical assessment field such as Biophysical Corporation and are pleased that the Biophysical250 will be used by the Tokyo Midtown Medical Center and available in Japan," said Mohan Chellappa, president of Amcare Labs International.

Amcare is in the business of helping clinical labs and medical facilities throughout the world define a new standard of excellence in global medicine by implementing the best laboratory and pathology technologies developed in the United States. Tokyo Midtown Medical Center recommends Biophysical250 to patients who want a comprehensive assessment of their health.

"Our mission is to provide the highest level of medical care in Japan," said Tetsuya Furukawa, president and COO of Tokyo Midtown Medical Center. "After months of careful evaluation we concluded that Biophysical250 is not only the best way to assess an individual's current state of health, but also to track improvement. The results provide our physicians with a comprehensive biomarker analysis that serves as the scientific foundation for further tests that can ultimately lead to the earlier detection of potentially serious conditions and diseases and the development of more effective treatment plans. We are fortunate to have expert guidance from our international partners as we evaluate new medical technologies such as Biophysical250 to benefit our patients. "

Tokyo Midtown Medical Center opened in March 2007 to provide Japanese and foreign executives with world-class medical care and health and wellness programs offered in a luxury environment. As Japan's first affiliation with John Hopkins Medicine International, Tokyo Midtown Medical Center is a comprehensive medical facility that incorporates the most technically advanced medical technology to assess and optimize quality of life for busy executives through thorough health screening, customized physical examinations and personalized health and wellness programs. Located in prestigious Tokyo Midtown, a new-style urban district that features Midtown Tower, the tallest structure in Tokyo, Tokyo Midtown Medical Center is situated at a "global crossroads" in Tokyo's major international business and cultural district that includes over 40 foreign embassies within a mile radius.

"Partnering with Amcare Labs with its affiliation to Johns Hopkins Medicine International provides us entry into unlimited international markets," said George Rodgers, president and chief medical officer for Biophysical Corporation. "We're pleased that our first international partner is Tokyo Midtown Medical Center, an outstanding state-of-the-art health and wellness facility that shares our philosophy on prevention and early detection."

About Amcare Labs International:
Founded in 2001, Amcare Labs International provides physicians, its partner labs, patients and institutions with the highest quality clinical and educational services available to assist people in obtaining true health through the adoption of the world's top medical technology. Through its unique affiliation with the clinical labs of Johns Hopkins Hospital and Johns Hopkins University, Amcare offers a broad array of tests and interpretations of medical information to its partner labs in international communities. More information about Amcare Labs is located at www.amcarelabs.com.

About Tokyo Midtown Medical Center:
Tokyo Midtown Medical Center is the first Japan-based collaboration with Johns Hopkins Medicine. Founded in 2007 to provide the most comprehensive medical care and health management to Japanese and foreign business executives, Tokyo Midtown Medical Center offers customized health and wellness programs based on the latest advancements in medical screening, diagnostics and assessment to meet the precise needs of each patient. More information about Tokyo Midtown Medical Center is located at http://www.tokyo-midtown.com/en/facilities/medical/index.html.

About Biophysical Corporation:
Biophysical Corporation is a private, Austin, Texas-based company dedicated to advancing clinical knowledge and quality of life for its clients. Formed in 2004, the company offers Biophysical250, the most comprehensive and advanced assessment of personal health ever developed. Through the innovative analysis of blood-based biomarkers, Biophysical250 may indicate the presence or risk of cancer, cardiovascular disease and other health risks often before symptoms appear. The company's management and advisory board includes internationally renowned physicians and scientists who are leaders in the field of biomarker research. More information about the company and Biophysical250 is available at www.biophysicalcorp.com or by calling 800.532.7092.

About Johns Hopkins Medicine International:
Leading a trend of rapid global changes in health, Johns Hopkins Medicine International works with international patients, physicians and institutions to bring the best of Johns Hopkins Medicine in research, education, training and clinical services to the world community. For more than a century, Johns Hopkins has set the standard of excellence in medical education, research and clinical care to fulfill its mission of improving the health of the community and the world.

In 2007, U.S. News & World Report named The Johns Hopkins Hospital the "Best of the Best" in its Honor Roll of "America's Best Hospitals" for the 17th consecutive year. To learn more please visit www.jhintl.net.

Biophysical and Biophysical250 are registered trademarks of Biophysical Corporation.

Biophysical250 results do not constitute a medical opinion or advice. These results are not medical care, treatment, a treatment recommendation or a diagnosis. Communication with medical professionals employed by Biophysical Corporation about the Biophysical250 or its results does not establish a physician-patient relationship.

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/Q291cC1JbnNlLVBpZ2ctTWFnbi1UaGlyLVplcm8=

biophysical250 johns hopkins medicine international biophysical corporation

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web